Decentering and Relapse/Recurrence in MBCT for Depression in Adults
Trial Summary
What is the purpose of this trial?
Objective: "Decentering" is defined as the ability to observe one's thoughts and feelings as temporary, objective events in the mind, and is increasingly regarded as a candidate mechanism in mindfulness-based interventions. The current study sought to examine the role of decentering, and other related variables, in the efficacy of Mindfulness-based cognitive therapy (MBCT) as compared to two active comparison conditions. Method: Formerly depressed individuals (N = 227), randomly assigned to MBCT (n = 74), relaxation group therapy (RGT; n = 77) or treatment-as-usual (TAU; n = 76), completed self-report measures of decentering and symptoms of depression at pre-, mid-, and post-treatment, and relapse was assessed at 3, 6, 9, and 12 months, post-treatment.
Research Team
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Mindfulness-based Cognitive Therapy (MBCT) (Behavioural Intervention)
- Relaxation Group Therapy (RGT) (Behavioural Intervention)
- Treatment as usual (TAU) (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Dr. Christopher Haqq
University of British Columbia
Chief Medical Officer since 2019
MD, University of British Columbia
Bekki Bracken Brown
University of British Columbia
Chief Executive Officer since 2023
Bachelor's degree from Duke University